معرفی
Lennie Derde serves as an Assistant Professor at Utrecht University and ICU consultant at UMC Utrecht, co-leading the “epidemiology of sepsis and inflammation” research group. She holds pivotal roles as European PI and immediate past global chair of REMAP-CAP, work package leader for EU-funded RECOVER and ECRAID-Base projects, and leader of the ZonMw-funded IMPRINT consortium.
Her research centers on optimizing clinical trials for critically ill patients with sepsis and severe infections, focusing on trial methodology, risk stratification, and novel treatments. She aims to establish rapid-response international research infrastructure for emerging infectious disease threats while advancing prevention, diagnosis, and therapeutic strategies in critical care.
Recent publications (2024-2025) demonstrate expertise in hydrocortisone efficacy for pneumonia, ARDS immunomodulation, and adaptive platform trial design. These works emphasize multinational methodology improvements and immune response dynamics in critical infections, reflecting her leadership in evidence-based critical care.
No major scientific awards were explicitly mentioned in the source material.
As principal investigator for IMPRINT, RECOVER, and ECRAID-Base, she directs significant grant-funded initiatives while contributing to the Surviving Sepsis Campaign Steering Committee and Sepsis Canada’s International Scientific Advisory Board. Her mentorship spans graduate researchers within UMC Utrecht’s clinical trial frameworks.
She co-leads the “Epidemiology of sepsis & inflammation in critically ill patients” research group, driving clinical epidemiological studies on infection management. Her work integrates with global networks like REMAP-CAP and the Surviving Sepsis Campaign to transform critical care practices through collaborative science.
